HIV Vaccine Innovation, Science, and Technology Acceleration in Africa (HIV-VISTA)
The summary for the HIV Vaccine Innovation, Science, and Technology Acceleration in Africa (HIV-VISTA) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Agency for International Development, which is the U.S. government agency offering this grant.
HIV Vaccine Innovation, Science, and Technology Acceleration in Africa (HIV-VISTA): The objective of the HIV-VISTA Project is to support sub-Saharan African scientists, institutions, and innovative systems of collaboration in designing and testing improved HIV vaccine candidates that will advance the field toward the long-term goal of a safe and globally-effective HIV vaccine.Activities should be implemented in at least three different countries in sub-Saharan AfricanClosing Date and Time for CONCEPT NOTE: Friday January 20, 2023; 4:00 PM, Washington DC local time Closing Date and Time for FULL APPLICATION (INVITATION ONLY): Wednesday May 3, 2023; at 4:00 PM, Washington DC local time Note: All Applicants that fit the Eligibility criteria are welcome to submit concept notes. At the concept stage, please submit proof documentation the eligibility. However, request for Full Application will be based on invitation. Therefore in order to be considered, all eligible Applicants interested must submit concept note by deadline to be considered for co-creation and Full Application. Please download and read all the relevant documents especially the NOFO Amendment 2 to understand the process.
| Federal Grant Title: | HIV Vaccine Innovation, Science, and Technology Acceleration in Africa (HIV-VISTA) |
| Federal Agency Name: | Agency for International Development (USAID) |
| Grant Categories: | Health |
| Type of Opportunity: | Other |
| Funding Opportunity Number: | 7200AA23RFA00002 |
| Type of Funding: | Cooperative Agreement |
| CFDA Numbers: | 98.001 |
| CFDA Descriptions: | Information not provided |
| Current Application Deadline: | May 3rd, 2023 |
| Original Application Deadline: | May 3rd, 2023 |
| Posted Date: | November 17th, 2022 |
| Creation Date: | November 17th, 2022 |
| Archive Date: | June 2nd, 2023 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | $46,000,000 |
| Minimum Federal Grant Award: | $46,000,000 |
| Expected Number of Awards: | 2 |
| Cost Sharing or Matching: | No |
| Last Updated: | December 21st, 2022 |
- Applicants Eligible for this Grant
- Public and State controlled institutions of higher education - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Eligibility for this NOFO is restricted to local entities in African countries, using the definition of “local entity” in the PEPFAR 2022 Country and Regional Operational Plan (COP/ROP). Per this guidance, local entity is defined as “an entity other than a sole proprietorship (such as a corporation or not-for-profit) must meet all three areas of eligibility:(1) EITHER, must be incorporated or legally organized under the laws of, and have its principal place of business in, the country or a country in the region served by the PEPFAR program with which the entity is or may become involved; OR must exist in the region where PEPFAR programs are implemented;(2) EITHER, must be at 75% beneficially owned at the time of application by individuals who are citizens or lawfully admitted permanent residents of that same country; OR at least 75% of the entity's staff (senior, mid-level, support) at the time of application must be citizens or lawfully admitted permanent residents of that same country; (3) Where an entity has a Board of Directors, at least 51% of the members of the Board must also be citizens or lawfully admitted permanent residents of such country.
- Link to Full Grant Announcement
- See Related Documents
- Grant Announcement Contact
- Simone Cho
A&A Specialist
If you have any difficulty assessing full announcement please contact me. - Similar Government Grants
- • Private Sector Collaboration Pathway (PSCP) Jordan Addendum
- • Request For Information-Local Works Mozambique
- • Strengthening Economic and Socio-Cultural Resilience of Tibetan Communities in South Asia
- • NPI Annual Program Statement (New Partnerships Initiative (NPI)/Conflict Prevention and Re...
- • Kenya Digital Health Ecosystem
- • Textbook and Learning Materials Program
- • Field-Support Program
- • FY-2005 Disaster Response Initiative in Northeast Sudan
- • YODA-7200AA20APS00007_Addendum
- • Development Innovation Ventures: Stage 4 Awards Annual Program Statement (APS)
- • GH Social and Behavior Change (SBC) Activity
- • 2024-draft-ifrp-transport-rfa-draft